NASDAQ:GRVI Upexi - GRVI Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Upexi, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $3.14 +0.02 (+0.64%) (As of 01/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$3.14▼$3.2550-Day Range$2.71▼$4.9552-Week Range$3.76▼$9.36Volume24,675 shsAverage Volume68,280 shsMarket Capitalization$52.76 millionP/E RatioN/ADividend YieldN/APrice TargetN/A ProfileChartCompetitorsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media About Upexi (NASDAQ:GRVI) StockGrove, Inc., through its subsidiaries, engages in developing, producing, marketing, and selling raw materials, white label products, and end consumer products containing the industrial hemp plant extract, cannabidiol. The company serves consumer markets, including the botanical, beauty care, pet care, and functional food sectors. It also operates annual tradeshow related to the CBD industry in the United States. The company was incorporated in 2018 and is headquartered in Henderson, Nevada.Read More Receive GRVI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Upexi and its competitors with MarketBeat's FREE daily newsletter. Email Address GRVI Stock News HeadlinesOctober 6, 2022 | nasdaq.comThe past year for Upexi (NASDAQ:UPXI) investors has not been profitable - NasdaqOctober 2, 2022 | finance.yahoo.comA Upexi, Inc. (NASDAQ:UPXI) insider increased their holdings by 5.3% last year - Yahoo FinanceJanuary 28, 2023 | Porter & Company (Ad)Is This The End of Capitalism?EXPOSED: The establishment plot to disenfranchise and impoverish millions of Americans…September 29, 2022 | finance.yahoo.comUpexi Revenue Increases 85% Year-Over-Year to $44.6 Million for Fiscal 2022 - Yahoo FinanceSeptember 28, 2022 | streetinsider.comForm 10-K UPEXI, INC. For: Jun 30 - StreetInsider.comAugust 20, 2022 | latimes.comMan fatally shot at Beverly Grove gas station; suspects remain at large - Los Angeles TimesAugust 19, 2022 | globenewswire.comStop & Shop Introduces Refreshed Grove Hall Store Focused on Community Health - GlobeNewswireAugust 18, 2022 | finance.yahoo.comEXCLUSIVE: Grove's Upexi Scoops LuckyTail Pet Care Company For Undisclosed TermsJanuary 28, 2023 | Porter & Company (Ad)The Next Big Crisis Is HereYou just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.August 17, 2022 | bizjournals.comElk Grove's Savvy House Coffee Bar may close soon, owner announces - Sacramento Business Journal - The Business JournalsAugust 16, 2022 | latimes.comActivists sue for the right to protest at the Grove - Los Angeles TimesAugust 16, 2022 | globenewswire.comGrove, Inc.'s Aggregation Division, Upexi, Acquires - GlobeNewswireAugust 16, 2022 | latimes.comCaruso's firm battles a studio expansion near the Grove - Los Angeles TimesAugust 16, 2022 | finance.yahoo.comGrove, Inc.’s Aggregation Division, Upexi, Acquires LuckyTail Pet Care Company in an All-Cash Transaction, Entering the $200 Billion International Pet MarketAugust 11, 2022 | businesswire.comGrove Announces Fiscal Second Quarter 2022 Financial Results - Business WireAugust 10, 2022 | marketwatch.comGrove Collaborative Up 19% - MarketWatchAugust 10, 2022 | forbes.comLeadership Lessons From The Orange Grove - ForbesAugust 10, 2022 | finance.yahoo.comUpdate: Grove, Inc. to Present at Sidoti August Microcap ConferenceAugust 10, 2022 | finance.yahoo.comGrove, Inc. to Present at Sidoti August Microcap ConferenceAugust 9, 2022 | bizjournals.comHines Interests tabbed for Elk Grove's Project Elevate - Sacramento Business Journal - The Business JournalsAugust 5, 2022 | latimes.comYosemite's Mariposa Grove reopens after monthlong wildfire closure - Los Angeles TimesAugust 4, 2022 | businesswire.comGrove to Report Second Quarter Fiscal 2022 Financial Results on August 11, 2022 - Business WireAugust 2, 2022 | globenewswire.comGrove, Inc's Aggregation Division, Upexi, Signs LOI to - GlobeNewswireAugust 2, 2022 | finance.yahoo.comGrove, Inc’s Aggregation Division, Upexi, Signs LOI to Acquire E-Core, Inc. and Its Subsidiaries Totaling $35M+ in TTM RevenuesJuly 28, 2022 | businesswire.comGrove Collaborative and Virgin Group Launch New Campaign Against Plastic With Brand Advocate Drew Barrymore and Sir Richard Branson - Business WireJuly 27, 2022 | businesswire.comStrategic Capital and Plaza Construction Commemorate 'Topping Out' At One Grove Street in Jersey City - Business WireJuly 26, 2022 | bizjournals.comRush Creek Apartments in Maple Grove sold for $74 million - Minneapolis / St. Paul Business Journal - The Business JournalsSee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive GRVI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Upexi and its competitors with MarketBeat's FREE daily newsletter. Email Address GRVI Company Calendar Today1/28/2023Fiscal Year End6/30/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medicinals & Botanicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:GRVI CUSIPN/A CIK1775194 Webgrovelabs.io Phone701-353-5425FaxN/AEmployees122Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$2.98 million Net Margins8.10% Pretax Margin5.43% Return on Equity12.48% Return on Assets10.39% Debt Debt-to-Equity RatioN/A Current Ratio2.35 Quick Ratio1.53 Sales & Book Value Annual Sales$24.09 million Price / Sales2.19 Cash Flow$0.19 per share Price / Cash Flow16.16 Book Value$1.49 per share Price / Book2.11Miscellaneous Outstanding Shares16,820,000Free Float7,576,000Market Cap$52.76 million OptionableNot Optionable Beta1.23 Key ExecutivesMr. Allan J. Marshall (Age 55)CEO & Chairman Comp: $1.03MMr. Robert Hackett (Age 35)Pres Comp: $175kMr. Andrew J. Norstrud (Age 50)CFO & Director Comp: $260kKey CompetitorsNatural Alternatives InternationalNASDAQ:NAIIValensNASDAQ:VLNSHEXONYSE:HEXOMannatechNASDAQ:MTEXMediWoundNASDAQ:MDWDView All CompetitorsInsiders & InstitutionsVanguard Group Inc.Bought 26,338 shares on 11/15/2022Ownership: 0.714%BlackRock Inc.Sold 2,786 shares on 11/15/2022Ownership: 0.099%ExodusPoint Capital Management LPBought 17,449 shares on 11/10/2022Ownership: 0.104%Gene SalkindBought 125,000 shares on 3/30/2022Total: $500,000.00 ($4.00/share)View All Insider TransactionsView All Institutional Transactions GRVI Stock - Frequently Asked Questions How have GRVI shares performed in 2023? Upexi's stock was trading at $3.00 on January 1st, 2023. Since then, GRVI shares have increased by 4.6% and is now trading at $3.1367. View the best growth stocks for 2023 here. When did Upexi IPO? (GRVI) raised $11 million in an IPO on Thursday, June 24th 2021. The company issued 2,200,000 shares at a price of $4.50-$5.50 per share. What is Upexi's stock symbol? Upexi trades on the NASDAQ under the ticker symbol "GRVI." How do I buy shares of Upexi? Shares of GRVI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Upexi's stock price today? One share of GRVI stock can currently be purchased for approximately $3.14. How much money does Upexi make? Upexi (NASDAQ:GRVI) has a market capitalization of $52.76 million and generates $24.09 million in revenue each year. How many employees does Upexi have? The company employs 122 workers across the globe. How can I contact Upexi? The official website for the company is grovelabs.io. The company can be reached via phone at 701-353-5425 or via email at john@tradigitalir.com. This page (NASDAQ:GRVI) was last updated on 1/28/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.